Transcription factors regulate miRNAs related to cardiac hypertrophy

No Pathway Network information available for Transcription factors regulate miRNAs related to cardiac hypertrophy

Pathways in the Transcription factors regulate miRNAs related to cardiac hypertrophy SuperPath

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

Disorders associated with Transcription factors regulate miRNAs related to cardiac hypertrophy SuperPath

according to GeneCards Suite gene sharing
#DisorderTypeGenesScore
1Proteus syndromeEnrichmentAKT13.18
2Hypoinsulinemic hypoglycemia with hemihypertrophyEnrichmentAKT23.18
3T-cell large granular lymphocyte leukemiaEnrichmentSTAT33.18
4Cowden syndrome 6EnrichmentAKT13.18
5Autoimmune disease, multisystem, infantile-onset, 1EnrichmentSTAT33.18
6Stat3-related early-onset multisystem autoimmune diseaseEnrichmentSTAT33.18
7Chronic lymphoproliferative disorder of natural killer cellsEnrichmentSTAT33.18
8Akt2-related familial partial lipodystrophyEnrichmentAKT23.18
9Camurati-engelmann disease 1EnrichmentTGFB12.88
10Albinism, oculocutaneous, type viEnrichmentMYEF22.88
11Immunodeficiency, common variable, 12, with autoimmunityEnrichmentNFKB12.88
12Inflammatory bowel disease, immunodeficiency, and encephalopathyEnrichmentTGFB12.88
13Camurati-engelmann diseaseEnrichmentTGFB12.88
14Common variable immunodeficiency 12EnrichmentNFKB12.88
15Hyper-ige syndrome 1, autosomal dominant, with recurrent infectionsEnrichmentSTAT32.70
16Breast implant-associated anaplastic large cell lymphomaEnrichmentSTAT32.70
17Hyper ige syndromeEnrichmentSTAT32.70
18Inflammatory bowel disease 25, autosomal recessiveEnrichmentTGFB12.40
19Il10-related early-onset inflammatory bowel diseaseEnrichmentTGFB12.40
20Breast adenocarcinomaEnrichmentAKT12.40
21Oculocutaneous albinismEnrichmentMYEF22.33
22Common variable immunodeficiencyEnrichmentNFKB12.33
23Permanent neonatal diabetes mellitusEnrichmentSTAT32.28
24Cowden syndromeEnrichmentAKT12.22
25Ciliary dyskinesia, primary, 3EnrichmentNFKB12.18
26MeningiomaEnrichmentAKT12.10
27Acute promyelocytic leukemiaEnrichmentSTAT32.07
28Diffuse large b-cell lymphomaEnrichmentSTAT31.90
29Cystic fibrosisEnrichmentTGFB11.68
30Type 2 diabetes mellitusEnrichmentAKT21.56
31Hereditary breast carcinomaEnrichmentAKT11.54
32Breast cancerEnrichmentAKT11.31
33Colorectal cancerEnrichmentAKT11.25
34Ovarian cancerEnrichmentAKT11.19

Loading...
Loading...
Loading...